Namhee Kim

Namhee Kim is a researcher at the South Korean biotechnology company Biorevert, where she focuses on reprogramming cancer cells to a benign state, aiming to avoid aggressive treatments. She has developed algorithms to identify molecular targets that could reverse lung cancer in preliminary studies.